A significant amount of funding has been allocated for cancer research. The goal is to enhance the efficacy of personalized cancer vaccines. This is made possible by a substantial grant.

Further information is available from the source regarding the specifics of the grant and its intended use.

The grant amount is $40M, awarded to UNC Lineberger, and is intended to produce valuable data to inform cancer vaccine development.